CCR3 ligand may be up-regulated by tumour-related inflammation and involved in the progress of renal cell carcinoma (74), whereas the CCR3/eotaxin-1 loop could induce malignant cell growth in T-cell lymphomas (75, 76). This evidence concerns the gene CCR3 and renal cell carcinoma.